Confirmatory Phase II/III Study Assessing Efficacy, Immunogenicity and Safety of IC43

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2014 by Valneva Austria GmbH
Sponsor:
Information provided by (Responsible Party):
Valneva Austria GmbH
ClinicalTrials.gov Identifier:
NCT01563263
First received: March 14, 2012
Last updated: September 11, 2014
Last verified: September 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2015
  Estimated Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)